h-header

news

News dal mondo

27

Gen

Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase

  • lobal pharmaceutical output surged in 2025 due to preemptive production ahead of U.S. tariff actions, with a 9.1% increase in manufacturing output.
  • The pharmaceutical sector benefits from structural resilience, stable demand, and strong credit conditions, supporting long-term investment despite economic uncertainties.....[PharmExec]

24

Feb

Industry clamors for clearer guidance on transition to ICH M4Q(R2)

The pharmaceutical industry has expressed a need for greater clarity regarding the timeline for converting...

23

Feb

USA . La Corte Suprema boccia i dazi globali di Trump: cosa cambia e perché il pharma resta nel mirino

l 20 febbraio 2026 la Supreme Court of the United States ha inferto un duro colpo alla strategia commerciale...

20

Feb

NerPharma acquistata da un colosso farmaceutico francese

N           Nerpharma, l’azienda di produzione farmaceutica del gruppo...

20

Feb

Generic industry against giving fee breaks to firms setting up operations in the US

The generic drug industry told the US Food and Drug Administration (FDA) that it opposes waiving annual...

slider-banner

h-footer